Overall verdict
Neutral
5.1/10
1-year performance
-21.00%
Score breakdown
Down 21.0% over 1 year, 61% of the 52-week range.
Strongest: Growth 10.0/10. Weakest: Shareholder return 0.0/10.
5 analysts, target +0.8% vs the price.
Strive, Inc. is a privately owned investment manager. It primarily provides its services to investment companies. The firm is a large advisory firm, an investment adviser to an investment company which provides portfolio management for investment companies. The firm invests in exchange traded funds. The firm conducts in-house research to make its investments. Strive, Inc. was founded in 2022 and is based in Dallas, Texas.
Sector
Health Care
Industry
Health Care Equipment and Supplies
Primary listing
Nasdaq
United States
CEO
Matthew Cole
Founded
2022
Employees
28
Revenue / employee
204 786 USD
Next earnings
March 19, 2027 (estimated)
Institutional holders
- FMR LLC9.62%
- GEODE CAPITAL MANAGEMENT, LLC1.49%
- Bank of New York Mellon Corp0.19%
- Rest of the register88.71%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
32.08 USD
52-week low
7.02 USD
1-year performance
-21.00%
Declining
Year-to-date performance
46.23%
Declining
Drawdown
-30.80%
Major drawdown
Position in the 52-week range
61% of range
Gross margin 23.4%, the company loses 2584.3% of its revenue, ROIC -12.6%, ROE -12.6%.
Net margin
-2584.29%
Negative
Sector 9.34%|S&P 13.40%
Gross margin
23.43%
Low
Return on equity (ROE)
-12.60%
Negative
Sector 7.45%|S&P 17.06%
Return on invested capital (ROIC)
-12.57%
Negative
Free cash flow margin (FCF)
-725.22%
Negative
Margin stability
2668.3 pts
Very uneven
Revenue to net income
Growth
10.0/10Revenue up 171.7% over 1 year, 131.1% a year over 5.
Revenue (trailing 12 months)
8.3M USD
Revenue growth (1y)
171.74%
Hyper-growth
Revenue growth (3y)
1571.20%
Hyper-growth
EPS growth (1y)
—
EPS CAGR (5y)
—
EPS revisions (3 months)
—
Valuation
0.0/10The company loses money, so no valuation multiple can be read: a negative P/E is not a discount.
P/E (TTM)
—
N/A (loss)
Sector 29.3x|S&P 23.6x
Forward P/E (adjusted)
—
N/A (loss)
EV / EBITDA
—
N/A (loss)
Sector 14.4x|S&P 15.5x
PEG
—
Sector 0.13|S&P 0.91
Market cap
2.8Md USD
Financial strength
5.8/10Cash covers 10428.1% of the debt, no net debt (net cash).
Net debt / EBITDA
—
Gearing (net debt / equity)
-12.56%
Net cash
Cash
336M USD
Cash / market cap
11.87%
Solid
Cash / total debt
10428.12%
Net cash
Interest coverage
-889.5x
Stretched
Net debt
-332M USD
Equity
2.6Md USD
Closed daily candles, 2 years
Last close on November 11, 2026: 23.21 USD
- MM2024.59
- MM5026.82
- MM20016.60
- RSI 1446.0
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+4.22%
200-day average slope, 3 months
+8.99%
50-day average slope, 1 month
+14.88%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
7.02 % per day
Volatility change
+37.32%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | -8.73 (1) | 1.36 (1) | 12 (4) | -60 (1) | -660 (1) |
| 2027 | -0.71 (1) | 18.97 (1) | 11 (4) | -58 (1) | -395 (1) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 6, 2026.
Same sub-industry: 187 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SYK | 6.5 | 6.1 | 121Md USD | 34.0x | 13.8 % | 7.6 % | 9.7 % | 1.7x | 3.8 % | -10.5 % | ||
| 2 | IDXX | 6.3 | 5.7 | 55.4Md USD | 47.4x | 25.4 % | 9.9 % | 54.9 % | 0.5x | 2.3 % | -1.2 % | ||
| 3 | ISRG | 6.2 | 5.5 | 156Md USD | 54.4x | 25.5 % | 21.7 % | 18.0 % | -1.6x | 2.3 % | -21.8 % | ||
| 4 | MDT | 6.2 | 6.7 | 130Md USD | 25.0x | 13.9 % | 13.7 % | 7.0 % | 2.0x | 4.7 % | 9.3 % | ||
| 5 | ABT | 6.0 | 5.2 | 189Md USD | 40.3x | 9.8 % | 14.5 % | 6.6 % | 0.5x | 3.6 % | -13.7 % | ||
| 6 | EW | 5.9 | 5.1 | 60.8Md USD | 61.6x | 14.9 % | 10.5 % | 8.9 % | -2.0x | 2.3 % | 25.3 % | ||
| 7 | BSX | 5.6 | 6.4 | 65.4Md USD | 19.1x | 16.6 % | 1.4 % | 9.8 % | 1.8x | 5.1 % | -55.5 % | ||
| 8 | BDX | 5.5 | 5.3 | 58.4Md USD | 51.8x | 7.4 % | -10.5 % | 3.6 % | 2.9x | 4.6 % | 49.4 % | ||
| 9 | ASST | 5.1 | 2.9 | 2.8Md USD | Not meaningful (loss) | -2584.3 % | 171.7 % | -12.6 % | — | -2.1 % | -21.0 % |
